Excellent interview. Congratulations!
In a short space of time, the interviewee touched on several points needed to be developed.
The abyssal differences in antimicrobial (AMC) use in poultry and swine production must undoubtedly be taken into account.
But... large companies and large cooperatives all operate in both segments. Why is the approach so different in the production chain?
Another point that needs to be discussed is the lack of reliable data on the use of AMC in animal production in Latin American countries. We don't have anything like MARAN (Netherlands) or DANMAP (Denmark), to start a more serious monitoring work.
It is up to veterinarians to have as much decision-making power as nutritionists in the Companies, who seek exclusively zootechnical results, at any cost.
I hope that ESG principles start to be more important in companies.